IDIX Related New Coverage
-
Baird Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral; No Great Pipeline but Patents Could Have Value
-
Deutsche Bank Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy
-
UPDATE: UBS Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy: Keys To Success
-
Maxim Group Starts Idenix Pharmaceuticals Inc. (IDIX) at Buy
-
Credit Suisse Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Neutral
-
Wedbush Assumes Coverage on Idenix Pharmaceuticals Inc. (IDIX) at Outperform; Market Potential for IDX184 Makes For Attractive Takeover Candidate
-
Barclays on U.S. Pharma: A New Era for Hep C Therapy - Starts Coverage on GILD & IDIX
-
Barclays Starts Idenix Pharmaceuticals (IDIX) at Equalweight
-
Wedbush Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral; IDX184 Has Blockbuster Potential, But Current Risk/Reward Balanced
-
JPMorgan Starts Idenix Pharmaceuticals Inc. (IDIX) at Overweight
-
Brean Murray Carret & Co. Starts Idenix Pharmaceuticals Inc. (IDIX) at Sell, $3 Price Target
-
Morgan Stanley Starts Idenix Pharmaceuticals Inc. (IDIX) at Equalweight
-
BofA/Merrill Lynch Starts Idenix Pharmaceuticals Inc. (IDIX) at Neutral
-
Gleacher & Co Initiates Coverage on Biotechnology/Drug Manufacturers Stocks (IDIX, VRUS, & VRTX)
-
Stifel Nicolaus Initiates Coverage on Idenix Pharmaceuticals (IDIX) with a Buy
-
Wedbush Assumes and Initiates Coverage on Several Key Biotech Players in Anti-Viral Space
-
Thomas Weisel Initiates Coverage on Idenix Pharmaceuticals (IDIX) with an Overweight
-
ThinkPanmure Initiates Coverage on Idenix Pharmaceuticals (IDIX) with an Accumulate
-
Oppenheimer Initiates Coverage on Idenix Pharmaceuticals (IDIX) with a Perform
-
Merrill Lynch Starts Idenix Pharma (IDIX) at Neutral
-
Morgan Joseph Initiates Coverage on Idenix Pharmaceuticals (IDIX) with a Buy
-
Piper Jaffray Starts Idenix Pharma (IDIX) at Underperform
-
Friedman Billings Starts IDIX at Outperform
-
JP Morgan Initiates IDIX
-
Citigroup Starts IDIX at Buy
-
IDIX started at Buy at ThinkEquity
Back to IDIX Stock Lookup
